nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevelamer—Peritonitis—Pazopanib—kidney cancer	0.0538	0.0538	CcSEcCtD
Sevelamer—Peritonitis—Everolimus—kidney cancer	0.0425	0.0425	CcSEcCtD
Sevelamer—Intestinal perforation—Temsirolimus—kidney cancer	0.0365	0.0365	CcSEcCtD
Sevelamer—Intestinal perforation—Pazopanib—kidney cancer	0.0344	0.0344	CcSEcCtD
Sevelamer—Diverticulitis—Sunitinib—kidney cancer	0.0275	0.0275	CcSEcCtD
Sevelamer—Intestinal perforation—Erlotinib—kidney cancer	0.0262	0.0262	CcSEcCtD
Sevelamer—Peritonitis—Paclitaxel—kidney cancer	0.0239	0.0239	CcSEcCtD
Sevelamer—Intestinal perforation—Sunitinib—kidney cancer	0.0227	0.0227	CcSEcCtD
Sevelamer—Intestinal perforation—Paclitaxel—kidney cancer	0.0152	0.0152	CcSEcCtD
Sevelamer—Ileus—Vinblastine—kidney cancer	0.0152	0.0152	CcSEcCtD
Sevelamer—Ileus—Everolimus—kidney cancer	0.0152	0.0152	CcSEcCtD
Sevelamer—Ileus—Erlotinib—kidney cancer	0.0146	0.0146	CcSEcCtD
Sevelamer—Faecalith—Doxorubicin—kidney cancer	0.0112	0.0112	CcSEcCtD
Sevelamer—Faecaloma—Doxorubicin—kidney cancer	0.0112	0.0112	CcSEcCtD
Sevelamer—Intestinal obstruction—Vincristine—kidney cancer	0.0111	0.0111	CcSEcCtD
Sevelamer—Ileus—Vincristine—kidney cancer	0.0107	0.0107	CcSEcCtD
Sevelamer—Abdominal distension—Temsirolimus—kidney cancer	0.00912	0.00912	CcSEcCtD
Sevelamer—Intestinal obstruction—Paclitaxel—kidney cancer	0.00884	0.00884	CcSEcCtD
Sevelamer—Abdominal distension—Pazopanib—kidney cancer	0.00859	0.00859	CcSEcCtD
Sevelamer—Ileus—Paclitaxel—kidney cancer	0.00851	0.00851	CcSEcCtD
Sevelamer—Intestinal obstruction—Capecitabine—kidney cancer	0.00726	0.00726	CcSEcCtD
Sevelamer—Ileus—Capecitabine—kidney cancer	0.00699	0.00699	CcSEcCtD
Sevelamer—Abdominal distension—Everolimus—kidney cancer	0.00678	0.00678	CcSEcCtD
Sevelamer—Flatulence—Pazopanib—kidney cancer	0.00586	0.00586	CcSEcCtD
Sevelamer—Abdominal distension—Sunitinib—kidney cancer	0.00567	0.00567	CcSEcCtD
Sevelamer—Arthralgia—Temsirolimus—kidney cancer	0.00537	0.00537	CcSEcCtD
Sevelamer—Arthralgia—Pazopanib—kidney cancer	0.00506	0.00506	CcSEcCtD
Sevelamer—Anorexia—Temsirolimus—kidney cancer	0.00491	0.00491	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Temsirolimus—kidney cancer	0.00469	0.00469	CcSEcCtD
Sevelamer—Flatulence—Everolimus—kidney cancer	0.00463	0.00463	CcSEcCtD
Sevelamer—Anorexia—Pazopanib—kidney cancer	0.00463	0.00463	CcSEcCtD
Sevelamer—Ileus—Doxorubicin—kidney cancer	0.0045	0.0045	CcSEcCtD
Sevelamer—Decreased appetite—Temsirolimus—kidney cancer	0.00448	0.00448	CcSEcCtD
Sevelamer—Flatulence—Erlotinib—kidney cancer	0.00446	0.00446	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00445	0.00445	CcSEcCtD
Sevelamer—Fatigue—Temsirolimus—kidney cancer	0.00444	0.00444	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.00442	0.00442	CcSEcCtD
Sevelamer—Constipation—Temsirolimus—kidney cancer	0.00441	0.00441	CcSEcCtD
Sevelamer—Pain—Temsirolimus—kidney cancer	0.00441	0.00441	CcSEcCtD
Sevelamer—Dyspepsia—Pazopanib—kidney cancer	0.00427	0.00427	CcSEcCtD
Sevelamer—Decreased appetite—Pazopanib—kidney cancer	0.00422	0.00422	CcSEcCtD
Sevelamer—Gastrointestinal pain—Temsirolimus—kidney cancer	0.00421	0.00421	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00419	0.00419	CcSEcCtD
Sevelamer—Fatigue—Pazopanib—kidney cancer	0.00418	0.00418	CcSEcCtD
Sevelamer—Pain—Pazopanib—kidney cancer	0.00415	0.00415	CcSEcCtD
Sevelamer—Abdominal pain—Temsirolimus—kidney cancer	0.00407	0.00407	CcSEcCtD
Sevelamer—Arthralgia—Everolimus—kidney cancer	0.004	0.004	CcSEcCtD
Sevelamer—Gastrointestinal pain—Pazopanib—kidney cancer	0.00397	0.00397	CcSEcCtD
Sevelamer—Flatulence—Sunitinib—kidney cancer	0.00386	0.00386	CcSEcCtD
Sevelamer—Arthralgia—Erlotinib—kidney cancer	0.00386	0.00386	CcSEcCtD
Sevelamer—Abdominal pain—Pazopanib—kidney cancer	0.00384	0.00384	CcSEcCtD
Sevelamer—Abdominal distension—Paclitaxel—kidney cancer	0.00381	0.00381	CcSEcCtD
Sevelamer—Asthenia—Temsirolimus—kidney cancer	0.0037	0.0037	CcSEcCtD
Sevelamer—Anorexia—Vinblastine—kidney cancer	0.00367	0.00367	CcSEcCtD
Sevelamer—Anorexia—Everolimus—kidney cancer	0.00365	0.00365	CcSEcCtD
Sevelamer—Pruritus—Temsirolimus—kidney cancer	0.00364	0.00364	CcSEcCtD
Sevelamer—Diarrhoea—Temsirolimus—kidney cancer	0.00352	0.00352	CcSEcCtD
Sevelamer—Anorexia—Erlotinib—kidney cancer	0.00352	0.00352	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00349	0.00349	CcSEcCtD
Sevelamer—Asthenia—Pazopanib—kidney cancer	0.00348	0.00348	CcSEcCtD
Sevelamer—Arthralgia—Sorafenib—kidney cancer	0.00347	0.00347	CcSEcCtD
Sevelamer—Pruritus—Pazopanib—kidney cancer	0.00343	0.00343	CcSEcCtD
Sevelamer—Dyspepsia—Everolimus—kidney cancer	0.00337	0.00337	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00337	0.00337	CcSEcCtD
Sevelamer—Decreased appetite—Vinblastine—kidney cancer	0.00334	0.00334	CcSEcCtD
Sevelamer—Arthralgia—Sunitinib—kidney cancer	0.00334	0.00334	CcSEcCtD
Sevelamer—Decreased appetite—Everolimus—kidney cancer	0.00333	0.00333	CcSEcCtD
Sevelamer—Diarrhoea—Pazopanib—kidney cancer	0.00332	0.00332	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Everolimus—kidney cancer	0.00331	0.00331	CcSEcCtD
Sevelamer—Fatigue—Everolimus—kidney cancer	0.0033	0.0033	CcSEcCtD
Sevelamer—Pain—Vinblastine—kidney cancer	0.00329	0.00329	CcSEcCtD
Sevelamer—Constipation—Vinblastine—kidney cancer	0.00329	0.00329	CcSEcCtD
Sevelamer—Constipation—Everolimus—kidney cancer	0.00328	0.00328	CcSEcCtD
Sevelamer—Pain—Everolimus—kidney cancer	0.00328	0.00328	CcSEcCtD
Sevelamer—Vomiting—Temsirolimus—kidney cancer	0.00328	0.00328	CcSEcCtD
Sevelamer—Dyspepsia—Erlotinib—kidney cancer	0.00325	0.00325	CcSEcCtD
Sevelamer—Rash—Temsirolimus—kidney cancer	0.00325	0.00325	CcSEcCtD
Sevelamer—Dermatitis—Temsirolimus—kidney cancer	0.00324	0.00324	CcSEcCtD
Sevelamer—Decreased appetite—Erlotinib—kidney cancer	0.00321	0.00321	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00319	0.00319	CcSEcCtD
Sevelamer—Fatigue—Erlotinib—kidney cancer	0.00319	0.00319	CcSEcCtD
Sevelamer—Anorexia—Sorafenib—kidney cancer	0.00317	0.00317	CcSEcCtD
Sevelamer—Pain—Erlotinib—kidney cancer	0.00316	0.00316	CcSEcCtD
Sevelamer—Constipation—Erlotinib—kidney cancer	0.00316	0.00316	CcSEcCtD
Sevelamer—Gastrointestinal pain—Vinblastine—kidney cancer	0.00315	0.00315	CcSEcCtD
Sevelamer—Gastrointestinal pain—Everolimus—kidney cancer	0.00313	0.00313	CcSEcCtD
Sevelamer—Abdominal distension—Capecitabine—kidney cancer	0.00312	0.00312	CcSEcCtD
Sevelamer—Vomiting—Pazopanib—kidney cancer	0.00309	0.00309	CcSEcCtD
Sevelamer—Rash—Pazopanib—kidney cancer	0.00306	0.00306	CcSEcCtD
Sevelamer—Nausea—Temsirolimus—kidney cancer	0.00306	0.00306	CcSEcCtD
Sevelamer—Dermatitis—Pazopanib—kidney cancer	0.00306	0.00306	CcSEcCtD
Sevelamer—Anorexia—Sunitinib—kidney cancer	0.00305	0.00305	CcSEcCtD
Sevelamer—Abdominal pain—Vinblastine—kidney cancer	0.00304	0.00304	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00303	0.00303	CcSEcCtD
Sevelamer—Abdominal pain—Everolimus—kidney cancer	0.00303	0.00303	CcSEcCtD
Sevelamer—Gastrointestinal pain—Erlotinib—kidney cancer	0.00302	0.00302	CcSEcCtD
Sevelamer—Dyspepsia—Sorafenib—kidney cancer	0.00293	0.00293	CcSEcCtD
Sevelamer—Abdominal pain—Erlotinib—kidney cancer	0.00292	0.00292	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00292	0.00292	CcSEcCtD
Sevelamer—Decreased appetite—Sorafenib—kidney cancer	0.00289	0.00289	CcSEcCtD
Sevelamer—Anorexia—Dactinomycin—kidney cancer	0.00289	0.00289	CcSEcCtD
Sevelamer—Nausea—Pazopanib—kidney cancer	0.00288	0.00288	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00287	0.00287	CcSEcCtD
Sevelamer—Fatigue—Sorafenib—kidney cancer	0.00287	0.00287	CcSEcCtD
Sevelamer—Constipation—Sorafenib—kidney cancer	0.00284	0.00284	CcSEcCtD
Sevelamer—Pain—Sorafenib—kidney cancer	0.00284	0.00284	CcSEcCtD
Sevelamer—Dyspepsia—Sunitinib—kidney cancer	0.00282	0.00282	CcSEcCtD
Sevelamer—Decreased appetite—Sunitinib—kidney cancer	0.00278	0.00278	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00276	0.00276	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00276	0.00276	CcSEcCtD
Sevelamer—Asthenia—Vinblastine—kidney cancer	0.00276	0.00276	CcSEcCtD
Sevelamer—Fatigue—Sunitinib—kidney cancer	0.00276	0.00276	CcSEcCtD
Sevelamer—Asthenia—Everolimus—kidney cancer	0.00275	0.00275	CcSEcCtD
Sevelamer—Pain—Sunitinib—kidney cancer	0.00274	0.00274	CcSEcCtD
Sevelamer—Constipation—Sunitinib—kidney cancer	0.00274	0.00274	CcSEcCtD
Sevelamer—Gastrointestinal pain—Sorafenib—kidney cancer	0.00272	0.00272	CcSEcCtD
Sevelamer—Pruritus—Everolimus—kidney cancer	0.00271	0.00271	CcSEcCtD
Sevelamer—Arthralgia—Gemcitabine—kidney cancer	0.00268	0.00268	CcSEcCtD
Sevelamer—Asthenia—Erlotinib—kidney cancer	0.00265	0.00265	CcSEcCtD
Sevelamer—Decreased appetite—Dactinomycin—kidney cancer	0.00263	0.00263	CcSEcCtD
Sevelamer—Diarrhoea—Vinblastine—kidney cancer	0.00263	0.00263	CcSEcCtD
Sevelamer—Abdominal pain—Sorafenib—kidney cancer	0.00263	0.00263	CcSEcCtD
Sevelamer—Diarrhoea—Everolimus—kidney cancer	0.00262	0.00262	CcSEcCtD
Sevelamer—Gastrointestinal pain—Sunitinib—kidney cancer	0.00262	0.00262	CcSEcCtD
Sevelamer—Pruritus—Erlotinib—kidney cancer	0.00262	0.00262	CcSEcCtD
Sevelamer—Fatigue—Dactinomycin—kidney cancer	0.00261	0.00261	CcSEcCtD
Sevelamer—Flatulence—Paclitaxel—kidney cancer	0.0026	0.0026	CcSEcCtD
Sevelamer—Pain—Dactinomycin—kidney cancer	0.00259	0.00259	CcSEcCtD
Sevelamer—Anorexia—Vincristine—kidney cancer	0.00258	0.00258	CcSEcCtD
Sevelamer—Abdominal pain—Sunitinib—kidney cancer	0.00253	0.00253	CcSEcCtD
Sevelamer—Diarrhoea—Erlotinib—kidney cancer	0.00253	0.00253	CcSEcCtD
Sevelamer—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00248	0.00248	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00247	0.00247	CcSEcCtD
Sevelamer—Anorexia—Gemcitabine—kidney cancer	0.00245	0.00245	CcSEcCtD
Sevelamer—Vomiting—Vinblastine—kidney cancer	0.00245	0.00245	CcSEcCtD
Sevelamer—Vomiting—Everolimus—kidney cancer	0.00244	0.00244	CcSEcCtD
Sevelamer—Rash—Everolimus—kidney cancer	0.00242	0.00242	CcSEcCtD
Sevelamer—Dermatitis—Everolimus—kidney cancer	0.00241	0.00241	CcSEcCtD
Sevelamer—Abdominal pain—Dactinomycin—kidney cancer	0.0024	0.0024	CcSEcCtD
Sevelamer—Asthenia—Sorafenib—kidney cancer	0.00239	0.00239	CcSEcCtD
Sevelamer—Decreased appetite—Vincristine—kidney cancer	0.00235	0.00235	CcSEcCtD
Sevelamer—Pruritus—Sorafenib—kidney cancer	0.00235	0.00235	CcSEcCtD
Sevelamer—Vomiting—Erlotinib—kidney cancer	0.00235	0.00235	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00234	0.00234	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Vincristine—kidney cancer	0.00234	0.00234	CcSEcCtD
Sevelamer—Fatigue—Vincristine—kidney cancer	0.00233	0.00233	CcSEcCtD
Sevelamer—Rash—Erlotinib—kidney cancer	0.00233	0.00233	CcSEcCtD
Sevelamer—Dermatitis—Erlotinib—kidney cancer	0.00233	0.00233	CcSEcCtD
Sevelamer—Pain—Vincristine—kidney cancer	0.00231	0.00231	CcSEcCtD
Sevelamer—Constipation—Vincristine—kidney cancer	0.00231	0.00231	CcSEcCtD
Sevelamer—Asthenia—Sunitinib—kidney cancer	0.0023	0.0023	CcSEcCtD
Sevelamer—Nausea—Vinblastine—kidney cancer	0.00228	0.00228	CcSEcCtD
Sevelamer—Nausea—Everolimus—kidney cancer	0.00228	0.00228	CcSEcCtD
Sevelamer—Diarrhoea—Sorafenib—kidney cancer	0.00228	0.00228	CcSEcCtD
Sevelamer—Pruritus—Sunitinib—kidney cancer	0.00226	0.00226	CcSEcCtD
Sevelamer—Arthralgia—Paclitaxel—kidney cancer	0.00224	0.00224	CcSEcCtD
Sevelamer—Decreased appetite—Gemcitabine—kidney cancer	0.00223	0.00223	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00222	0.00222	CcSEcCtD
Sevelamer—Fatigue—Gemcitabine—kidney cancer	0.00221	0.00221	CcSEcCtD
Sevelamer—Gastrointestinal pain—Vincristine—kidney cancer	0.00221	0.00221	CcSEcCtD
Sevelamer—Pain—Gemcitabine—kidney cancer	0.0022	0.0022	CcSEcCtD
Sevelamer—Constipation—Gemcitabine—kidney cancer	0.0022	0.0022	CcSEcCtD
Sevelamer—Nausea—Erlotinib—kidney cancer	0.0022	0.0022	CcSEcCtD
Sevelamer—Diarrhoea—Sunitinib—kidney cancer	0.00219	0.00219	CcSEcCtD
Sevelamer—Asthenia—Dactinomycin—kidney cancer	0.00217	0.00217	CcSEcCtD
Sevelamer—Abdominal pain—Vincristine—kidney cancer	0.00214	0.00214	CcSEcCtD
Sevelamer—Flatulence—Capecitabine—kidney cancer	0.00213	0.00213	CcSEcCtD
Sevelamer—Vomiting—Sorafenib—kidney cancer	0.00211	0.00211	CcSEcCtD
Sevelamer—Rash—Sorafenib—kidney cancer	0.0021	0.0021	CcSEcCtD
Sevelamer—Dermatitis—Sorafenib—kidney cancer	0.0021	0.0021	CcSEcCtD
Sevelamer—Diarrhoea—Dactinomycin—kidney cancer	0.00207	0.00207	CcSEcCtD
Sevelamer—Anorexia—Paclitaxel—kidney cancer	0.00205	0.00205	CcSEcCtD
Sevelamer—Vomiting—Sunitinib—kidney cancer	0.00203	0.00203	CcSEcCtD
Sevelamer—Rash—Sunitinib—kidney cancer	0.00202	0.00202	CcSEcCtD
Sevelamer—Dermatitis—Sunitinib—kidney cancer	0.00202	0.00202	CcSEcCtD
Sevelamer—Abdominal distension—Doxorubicin—kidney cancer	0.00201	0.00201	CcSEcCtD
Sevelamer—Nausea—Sorafenib—kidney cancer	0.00198	0.00198	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00196	0.00196	CcSEcCtD
Sevelamer—Asthenia—Vincristine—kidney cancer	0.00194	0.00194	CcSEcCtD
Sevelamer—Vomiting—Dactinomycin—kidney cancer	0.00193	0.00193	CcSEcCtD
Sevelamer—Rash—Dactinomycin—kidney cancer	0.00191	0.00191	CcSEcCtD
Sevelamer—Nausea—Sunitinib—kidney cancer	0.0019	0.0019	CcSEcCtD
Sevelamer—Dyspepsia—Paclitaxel—kidney cancer	0.00189	0.00189	CcSEcCtD
Sevelamer—Decreased appetite—Paclitaxel—kidney cancer	0.00187	0.00187	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00186	0.00186	CcSEcCtD
Sevelamer—Fatigue—Paclitaxel—kidney cancer	0.00185	0.00185	CcSEcCtD
Sevelamer—Diarrhoea—Vincristine—kidney cancer	0.00185	0.00185	CcSEcCtD
Sevelamer—Asthenia—Gemcitabine—kidney cancer	0.00184	0.00184	CcSEcCtD
Sevelamer—Arthralgia—Capecitabine—kidney cancer	0.00184	0.00184	CcSEcCtD
Sevelamer—Constipation—Paclitaxel—kidney cancer	0.00184	0.00184	CcSEcCtD
Sevelamer—Pain—Paclitaxel—kidney cancer	0.00184	0.00184	CcSEcCtD
Sevelamer—Pruritus—Gemcitabine—kidney cancer	0.00182	0.00182	CcSEcCtD
Sevelamer—Nausea—Dactinomycin—kidney cancer	0.0018	0.0018	CcSEcCtD
Sevelamer—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00176	0.00176	CcSEcCtD
Sevelamer—Diarrhoea—Gemcitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Sevelamer—Vomiting—Vincristine—kidney cancer	0.00172	0.00172	CcSEcCtD
Sevelamer—Rash—Vincristine—kidney cancer	0.00171	0.00171	CcSEcCtD
Sevelamer—Dermatitis—Vincristine—kidney cancer	0.00171	0.00171	CcSEcCtD
Sevelamer—Abdominal pain—Paclitaxel—kidney cancer	0.0017	0.0017	CcSEcCtD
Sevelamer—Anorexia—Capecitabine—kidney cancer	0.00168	0.00168	CcSEcCtD
Sevelamer—Vomiting—Gemcitabine—kidney cancer	0.00163	0.00163	CcSEcCtD
Sevelamer—Rash—Gemcitabine—kidney cancer	0.00162	0.00162	CcSEcCtD
Sevelamer—Dermatitis—Gemcitabine—kidney cancer	0.00162	0.00162	CcSEcCtD
Sevelamer—Nausea—Vincristine—kidney cancer	0.00161	0.00161	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00161	0.00161	CcSEcCtD
Sevelamer—Dyspepsia—Capecitabine—kidney cancer	0.00155	0.00155	CcSEcCtD
Sevelamer—Asthenia—Paclitaxel—kidney cancer	0.00154	0.00154	CcSEcCtD
Sevelamer—Decreased appetite—Capecitabine—kidney cancer	0.00153	0.00153	CcSEcCtD
Sevelamer—Nausea—Gemcitabine—kidney cancer	0.00153	0.00153	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00152	0.00152	CcSEcCtD
Sevelamer—Fatigue—Capecitabine—kidney cancer	0.00152	0.00152	CcSEcCtD
Sevelamer—Pruritus—Paclitaxel—kidney cancer	0.00152	0.00152	CcSEcCtD
Sevelamer—Constipation—Capecitabine—kidney cancer	0.00151	0.00151	CcSEcCtD
Sevelamer—Pain—Capecitabine—kidney cancer	0.00151	0.00151	CcSEcCtD
Sevelamer—Diarrhoea—Paclitaxel—kidney cancer	0.00147	0.00147	CcSEcCtD
Sevelamer—Gastrointestinal pain—Capecitabine—kidney cancer	0.00144	0.00144	CcSEcCtD
Sevelamer—Abdominal pain—Capecitabine—kidney cancer	0.00139	0.00139	CcSEcCtD
Sevelamer—Flatulence—Doxorubicin—kidney cancer	0.00137	0.00137	CcSEcCtD
Sevelamer—Vomiting—Paclitaxel—kidney cancer	0.00137	0.00137	CcSEcCtD
Sevelamer—Rash—Paclitaxel—kidney cancer	0.00136	0.00136	CcSEcCtD
Sevelamer—Dermatitis—Paclitaxel—kidney cancer	0.00135	0.00135	CcSEcCtD
Sevelamer—Nausea—Paclitaxel—kidney cancer	0.00128	0.00128	CcSEcCtD
Sevelamer—Asthenia—Capecitabine—kidney cancer	0.00127	0.00127	CcSEcCtD
Sevelamer—Pruritus—Capecitabine—kidney cancer	0.00125	0.00125	CcSEcCtD
Sevelamer—Diarrhoea—Capecitabine—kidney cancer	0.00121	0.00121	CcSEcCtD
Sevelamer—Arthralgia—Doxorubicin—kidney cancer	0.00119	0.00119	CcSEcCtD
Sevelamer—Vomiting—Capecitabine—kidney cancer	0.00112	0.00112	CcSEcCtD
Sevelamer—Rash—Capecitabine—kidney cancer	0.00111	0.00111	CcSEcCtD
Sevelamer—Dermatitis—Capecitabine—kidney cancer	0.00111	0.00111	CcSEcCtD
Sevelamer—Anorexia—Doxorubicin—kidney cancer	0.00108	0.00108	CcSEcCtD
Sevelamer—Nausea—Capecitabine—kidney cancer	0.00105	0.00105	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.00104	0.00104	CcSEcCtD
Sevelamer—Dyspepsia—Doxorubicin—kidney cancer	0.001	0.001	CcSEcCtD
Sevelamer—Decreased appetite—Doxorubicin—kidney cancer	0.000989	0.000989	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000982	0.000982	CcSEcCtD
Sevelamer—Fatigue—Doxorubicin—kidney cancer	0.000981	0.000981	CcSEcCtD
Sevelamer—Constipation—Doxorubicin—kidney cancer	0.000973	0.000973	CcSEcCtD
Sevelamer—Pain—Doxorubicin—kidney cancer	0.000973	0.000973	CcSEcCtD
Sevelamer—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00093	0.00093	CcSEcCtD
Sevelamer—Abdominal pain—Doxorubicin—kidney cancer	0.000899	0.000899	CcSEcCtD
Sevelamer—Asthenia—Doxorubicin—kidney cancer	0.000816	0.000816	CcSEcCtD
Sevelamer—Pruritus—Doxorubicin—kidney cancer	0.000805	0.000805	CcSEcCtD
Sevelamer—Diarrhoea—Doxorubicin—kidney cancer	0.000778	0.000778	CcSEcCtD
Sevelamer—Vomiting—Doxorubicin—kidney cancer	0.000723	0.000723	CcSEcCtD
Sevelamer—Rash—Doxorubicin—kidney cancer	0.000717	0.000717	CcSEcCtD
Sevelamer—Dermatitis—Doxorubicin—kidney cancer	0.000716	0.000716	CcSEcCtD
Sevelamer—Nausea—Doxorubicin—kidney cancer	0.000676	0.000676	CcSEcCtD
